Geneesmiddelenbeleid

This motion concerns the general framework and strategy for pharmaceutical policy in the Netherlands. It aims to address how medicines are managed, procured, and regulated to ensure public health and sustainable healthcare spending. This procedure affects patients, healthcare providers, and pharmaceutical companies by potentially altering how medicines are accessed and priced within the Dutch healthcare system.